These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1105059)

  • 21. On the method of evaluating the development of an embryonic component in experimental teratology.
    Jelínek R; Dostál M
    Folia Morphol (Praha); 1972; 20(2):130-3. PubMed ID: 5021670
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental congenital malformations of the motorskeletal system.
    Pappas AM
    Clin Orthop Relat Res; 1968; 59():249-76. PubMed ID: 4874883
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse pregnancy outcome: sensitive periods, types of adverse outcomes, and relationships with critical exposure periods.
    Kochenour NK
    Prog Clin Biol Res; 1984; 160():229-35. PubMed ID: 6382329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rationale for models studying mechanisms of teratogenesis.
    Jelínek R
    Prog Clin Biol Res; 1985; 163C():221-6. PubMed ID: 3991625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Mendelian development defects: animal models and implications for research into human disease.
    Bull World Health Organ; 1977; 55(4):475-87. PubMed ID: 413638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teratogenesis in cats associated with griseofulvin therapy.
    Scott FW; LaHunta A; Schultz RD; Bistner SI; Riis RC
    Teratology; 1975 Feb; 11(1):79-86. PubMed ID: 806126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of cleft palate, palatal slit, and fetal death in mice treated with a glucocorticoid: an embryo transfer experiment.
    Kusanagi T
    Teratology; 1983 Jun; 27(3):395-400. PubMed ID: 6879461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect on mestranol on the gravidity of mice].
    Heinecke H; Klaus S
    Pharmazie; 1975 Jan; 30(1):53-6. PubMed ID: 1135246
    [No Abstract]   [Full Text] [Related]  

  • 30. [The radioembriologic effect and its importance in pathology].
    Piontkovskiĭ IA
    Patol Fiziol Eksp Ter; 1967; 11(6):13-20. PubMed ID: 4903384
    [No Abstract]   [Full Text] [Related]  

  • 31. The multifactorial/threshold concept -- uses and misuses.
    Fraser FC
    Teratology; 1976 Dec; 14(3):267-80. PubMed ID: 1033611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embryonic neuropathy. A hypothesis of neural chest injury as the pathogenesis of congenital malformations.
    McCredie J
    Med J Aust; 1974 Feb; 1(6):159-63. PubMed ID: 4206885
    [No Abstract]   [Full Text] [Related]  

  • 33. Zoonotic Ljungan virus associated with central nervous system malformations in terminated pregnancy.
    Niklasson B; Samsioe A; Papadogiannakis N; Gustafsson S; Klitz W
    Birth Defects Res A Clin Mol Teratol; 2009 Jun; 85(6):542-5. PubMed ID: 19180651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craniofacial growth during human secondary palate formation and potential relevance of experimental cleft palate observations.
    Diewert VM
    J Craniofac Genet Dev Biol Suppl; 1986; 2():267-76. PubMed ID: 3491117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of known environmental teratogens: drugs and chemicals.
    Beckman DA; Brent RL
    Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Are microwaves a co-teratogen? Experimental model concept and its verification].
    Marcickiewicz J; Chazan B; Troszyński M; Szmigielski S
    Probl Med Wieku Rozwoj; 1984; 13():168-75. PubMed ID: 6531346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of mammalian models in teratology.
    Palmer AK
    Prog Clin Biol Res; 1985; 163A():97-106. PubMed ID: 3969396
    [No Abstract]   [Full Text] [Related]  

  • 39. Process of building biologically based dose-response models for developmental defects.
    Gaylor DW; Razzaghi M
    Teratology; 1992 Dec; 46(6):573-81. PubMed ID: 1290158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of clorazicin on embryonal development of mice and rats].
    Smol'nikova NM; Petrova IV; Mudrova VK
    Farmakol Toksikol; 1969; 32(6):732-5. PubMed ID: 5381610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.